Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/17/2003WO2003057863A2 Cloning methods and other methods of producing cells
07/17/2003WO2003057859A2 Genes for altering mitochondrial function and for hybrid seed production
07/17/2003WO2003057857A2 Antibodies directed to pdgfd and uses thereof
07/17/2003WO2003057856A2 Dominant negative proteins and methods thereof
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057849A2 Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats
07/17/2003WO2003057848A2 A method to maintain a genic male-sterile female parental line of wheat through selfing of the maintainer line
07/17/2003WO2003057847A2 METHODS AND MATERIALS FOR MODULATING ENaC-BETA
07/17/2003WO2003057846A2 Methods and materials for modulating task-3
07/17/2003WO2003057843A2 Methods and materials for modulating trpc4
07/17/2003WO2003057842A2 Aggrecanase molecules
07/17/2003WO2003057841A2 Remote homologues and kinases and methods of detection
07/17/2003WO2003057840A2 Compositions for dna mediated gene silencing
07/17/2003WO2003057837A2 Methods for using anti-muc18 antibodies
07/17/2003WO2003057836A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
07/17/2003WO2003057835A2 Pak5-related compositions and methods
07/17/2003WO2003057834A2 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
07/17/2003WO2003057833A2 Mutant chromophores/fluorophores and methods for making and using the same
07/17/2003WO2003057830A2 Compositions and methods for hydroxylating epothilones
07/17/2003WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003WO2003057826A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE
07/17/2003WO2003057823A2 Epitope synchronization in antigen presenting cells
07/17/2003WO2003057822A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
07/17/2003WO2003057731A2 Human pheromone receptors
07/17/2003WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
07/17/2003WO2003057729A2 Mammal prolactin variants
07/17/2003WO2003057728A1 A novel splice variant of myd88 and uses thereof
07/17/2003WO2003057727A1 Methods of producing silk polypeptides and products thereof
07/17/2003WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/17/2003WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
07/17/2003WO2003057713A2 Proteases producing an altered immunogenic response and methods of making and using the same
07/17/2003WO2003057711A2 Isolated cytokine receptor licr-2
07/17/2003WO2003057708A2 Fusion proteins
07/17/2003WO2003057252A1 Human mast cell-expressed membrane proteins
07/17/2003WO2003057248A1 Thermotolerant phytase for animal feed
07/17/2003WO2003057246A1 Proteases producing an altered immunological response and methods of making and using the same
07/17/2003WO2003057178A2 Viral capsid assembly intermediates
07/17/2003WO2003057174A2 Methods and compositions for protein expression and purification
07/17/2003WO2003057168A2 Cancer-associated epitope
07/17/2003WO2003057164A2 Compounds for delivering substances into cells
07/17/2003WO2003057160A2 Compositions and methods for the diagnosis and treatment of tumor
07/17/2003WO2003057159A2 Psoriasin expression by breast epithelial cells
07/17/2003WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003WO2003057146A2 Novel compositions and methods for cancer
07/17/2003WO2003057142A2 Antisense modulation of macrophage inflammatory protein 3-alpha expression
07/17/2003WO2003057134A2 Specific binding agents of human angiopoietin-2
07/17/2003WO2003057130A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003WO2003056914A1 Methods to engineer mammalian-type carbohydrate structures
07/17/2003WO2003056913A1 Nonhuman model animal lacking the ability to control lymphocyte migration
07/17/2003WO2003056912A2 Inducible transposition in transgenic organism using transposon vector
07/17/2003WO2003056905A1 Method of constructing chimeric plant by heavy ion beam irradiation
07/17/2003WO2003056904A2 Transgenic plants expressing civps or intein modified proteins and related method
07/17/2003WO2003047507A3 Factor viii c2 domain variants
07/17/2003WO2003046172A3 Alzheimer’s disease model
07/17/2003WO2003039243A3 Amine oxidase stress-related polypeptides and methods of use in plants
07/17/2003WO2003038057A3 Genetic vaccine against human immunodeficiency virus
07/17/2003WO2003035892A3 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
07/17/2003WO2003035838A3 Stem cells that transform to beating cardiomyocytes
07/17/2003WO2003031595A3 Molecules for disease detection and treatment
07/17/2003WO2003018800A3 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
07/17/2003WO2003008573A3 Silencing of gene expression by sirna
07/17/2003WO2003004626B1 A bioprocess for the generation of cells derived from spheroid-forming cells
07/17/2003WO2003004595A3 Materials and methods relating to protein and nucleic acid evolution
07/17/2003WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
07/17/2003WO2002101067A3 Process for the preparation of d-pantothenic acid and/or salts thereof
07/17/2003WO2002101066A3 Process for the preparation of d-pantothenic acid and/or salts thereof
07/17/2003WO2002101063A3 Process for the preparation of d-pantothenic acid and/or salts thereof
07/17/2003WO2002101055A3 Process for the preparation of d-pantothenic acid and/or salts thereof
07/17/2003WO2002099044A3 B3galts as modifiers of the p53 pathway and methods of use
07/17/2003WO2002090566A3 Recombinant tumor specific antibody and use thereof
07/17/2003WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
07/17/2003WO2002081684A3 Antisense calpain nucleotides and uses thereof
07/17/2003WO2002081646A3 Epitope sequences
07/17/2003WO2002081633A3 A bardet-biedl susceptibility gene and uses thereof
07/17/2003WO2002077233A8 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
07/17/2003WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility
07/17/2003WO2002059286A3 Adenylate cyclases
07/17/2003WO2002058323A3 Method for identifying modulators of bace
07/17/2003WO2002057450A3 Proteins and nucleic acids encoding same
07/17/2003WO2002055693A3 Method for inhibiting the expression of a target gene
07/17/2003WO2002048195A3 Engineered stimulus-responsive switches
07/17/2003WO2002047478A3 Transgenic mice containing proliferator-activated receptor gene disruptions
07/17/2003WO2002044201A3 Haplotypes of the sah gene
07/17/2003WO2002040715A3 Molecules for disease detection and treatment
07/17/2003WO2002040687A9 Tissue specific promoters from the sugar beet
07/17/2003WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/17/2003WO2002032962A3 Compositions of human proteins and method of use thereof
07/17/2003WO2002031134A3 Novel serine protease genes related to dppiv
07/17/2003WO2002029060A9 Hematopoietin receptors hpr1 and hpr2
07/17/2003WO2002026998A3 Hydrolases
07/17/2003WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses
07/17/2003WO2002022660A3 Novel nucleic acids and polypeptides
07/17/2003WO2002017858A9 Role of fosb in bone formation
07/17/2003WO2002008469A3 Methods, systems, and articles of manufacture for evaluating biological data
07/17/2003WO2002006479A3 Apoptosis-inducing dna sequences
07/17/2003WO2002002227A8 Devices and methods for carrying out chemical reactions using photogenerated reagents
07/17/2003WO2001070943A3 Stable composition comprising a nuclease and a phosphatase
07/17/2003WO2001064869A9 Tumor-related antigen
07/17/2003US20030135891 Method of transforming intact plants
07/17/2003US20030135890 Nucleic acids that control plant development
1 ... 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 ... 4023